| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 0.0 | 0.0 | 21.2 |
| Other income | 0.0 | 1.5 | 1.9 |
| Total income | 0.0 | 1.5 | 23.1 |
| Profit before exceptional items & tax | -49.9 | 1.4 | 2.5 |
| Profit before tax | -49.9 | 1.4 | 2.5 |
| Net profit | -49.9 | 1.1 | 2.5 |
| Operating margin | 0.0% | 93.3% | 10.8% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
Source
Read the filing ↗
BSE results filing, NSE: WELCURE. Figures extracted from the filing.
Welcure Drugs & Pharmaceuticals Ltd: key numbers
- Share price
- ₹0.22
- Market cap
- ₹27.19 Cr
- Revenue (annual)
- ₹365.5 Cr
- Net profit (annual)
- ₹-5.49 Cr
- P/E (TTM)
- -1.6×Sector 50.4×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.